The Clorox Company (NYSE:CLX – Get Free Report) Director Pierre Breber bought 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Clorox Stock Performance
CLX stock opened at $86.17 on Wednesday. The firm has a market cap of $10.42 billion, a PE ratio of 13.99, a P/E/G ratio of 0.45 and a beta of 0.59. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The business has a 50 day moving average of $107.46 and a 200-day moving average of $108.43. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $138.94.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the company posted $1.45 earnings per share. Clorox’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, sell-side analysts expect that The Clorox Company will post 5.63 earnings per share for the current year.
Clorox Dividend Announcement
Analysts Set New Price Targets
A number of research firms recently issued reports on CLX. Wells Fargo & Company decreased their price objective on shares of Clorox from $110.00 to $100.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. Evercore reiterated an “underperform” rating and issued a $110.00 target price on shares of Clorox in a research note on Friday. The Goldman Sachs Group reissued a “sell” rating and set a $83.00 target price on shares of Clorox in a research report on Friday. JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. Finally, Royal Bank Of Canada lowered their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a report on Thursday, April 9th. One research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, Clorox presently has a consensus rating of “Reduce” and an average target price of $104.00.
View Our Latest Research Report on CLX
Institutional Investors Weigh In On Clorox
A number of institutional investors and hedge funds have recently modified their holdings of CLX. Allspring Global Investments Holdings LLC boosted its position in shares of Clorox by 3.5% in the first quarter. Allspring Global Investments Holdings LLC now owns 5,237 shares of the company’s stock valued at $546,000 after acquiring an additional 177 shares during the period. Independent Financial Group LLC bought a new stake in Clorox during the 1st quarter worth approximately $420,000. Wealthfront Advisers LLC lifted its stake in Clorox by 18.5% in the 1st quarter. Wealthfront Advisers LLC now owns 3,690 shares of the company’s stock worth $382,000 after purchasing an additional 575 shares in the last quarter. D.A. Davidson & CO. lifted its stake in Clorox by 8.8% in the 1st quarter. D.A. Davidson & CO. now owns 20,674 shares of the company’s stock worth $2,142,000 after purchasing an additional 1,676 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in Clorox by 2.3% in the 1st quarter. Bank of New York Mellon Corp now owns 1,280,226 shares of the company’s stock valued at $132,670,000 after purchasing an additional 29,181 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.
Clorox Company Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Articles
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
